FCM regimen: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}}FCMR Regimen; R-FCM Regimen; Rituximab-Fludarabine-Cyclophosphamide-Mitoxantrone Regimen ==Overview== {{PAGENAME}} refers to...")
 
(Redirected page to FMC regimen)
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT[[FMC regimen]]
{{SI}} {{CMG}}; {{AE}} {{AV}}
 
{{SK}}FCMR Regimen; R-FCM Regimen; Rituximab-Fludarabine-Cyclophosphamide-Mitoxantrone Regimen
 
==Overview==
 
{{PAGENAME}} refers to a regimen consisting of [[fludarabine]], [[cyclophosphamide]], [[mitoxantrone]] and [[rituximab]] used to treat indolent [[non-Hodgkin's lymphoma]] and relapsed or refractory [[mantle cell lymphoma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63463&ns=NCI_Thesaurus}}</ref>
 
 
==Regimen==
 
 
{{chemo|F|Fludarabine}}
{{chemo|C|Cyclophosphamide}}
{{chemo|M|Mitoxantrone}}
==Indications==
 
*Indolent [[non-Hodgkin's lymphoma]] and relapsed or refractory [[mantle cell lymphoma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63463&ns=NCI_Thesaurus}}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Chemotherapy regimens]]

Latest revision as of 16:19, 31 March 2015

Redirect to: